Valuation: Healthconn Corp.

Market Cap 952M 29.67M 25.95M 23.94M 22.11M 41.96M 2.83B 42.66M 286M 112M 1.39B 111M 109M 4.79B P/E 2024
43.8x
P/E 2025 108x
Enterprise Value 833M 25.96M 22.71M 20.94M 19.34M 36.7M 2.48B 37.32M 250M 98.27M 1.22B 97.47M 95.34M 4.19B EV / Sales 2024
0.41x
EV / Sales 2025 0.7x
Free-Float
58.01%
Yield 2024
3.81%
Yield 2025 0.74%
1 week+5.53%
Current month+6.06%
1 month+5.00%
3 months+7.69%
6 months+6.33%
Current year+4.74%
1 week 19.5
Extreme 19.5
21.2
1 month 18.5
Extreme 18.5
21.55
Current year 18.4
Extreme 18.4
24.4
1 year 18.4
Extreme 18.4
26.15
3 years 16.9
Extreme 16.9
38.75
5 years 16.9
Extreme 16.9
57.2
10 years 16.9
Extreme 16.9
247.02
Manager TitleAgeSince
Chief Executive Officer - 2023-12-20
Director of Finance/CFO - 2018-12-20
Comptroller/Controller/Auditor - 2021-03-21
Director TitleAgeSince
Director/Board Member - 2017-12-26
Director/Board Member - 2020-06-21
Director/Board Member - 2022-06-16
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.53%-12.68%-40.00% 29.67M
-0.04%+1.57%-20.41%-30.66% 185M
+0.17%-2.36%-35.20%-57.73% 176M
-3.37%+3.61%-28.03%+7.67% 55.13M
Average -0.81%+2.09%-24.08%-30.18% 111.64M
Weighted average by Cap. -0.37%+0.53%-26.68%-37.25%

Financials

2024 2025
Net sales 1.25B 39.05M 34.16M 31.51M 29.1M 55.21M 3.72B 56.14M 376M 148M 1.83B 147M 143M 6.31B 1.13B 35.24M 30.82M 28.43M 26.26M 49.83M 3.36B 50.66M 340M 133M 1.66B 132M 129M 5.69B
Net income 19.23M 599K 524K 483K 446K 847K 57.14M 861K 5.78M 2.27M 28.15M 2.25M 2.2M 96.77M 8.39M 262K 229K 211K 195K 370K 24.94M 376K 2.52M 990K 12.29M 982K 961K 42.24M
Net Debt -317M -9.89M -8.65M -7.98M -7.37M -13.99M -943M -14.22M -95.35M -37.45M -465M -37.14M -36.33M -1.6B -119M -3.71M -3.25M -3M -2.77M -5.25M -354M -5.34M -35.81M -14.06M -175M -13.95M -13.64M -600M
Logo Healthconn Corp.
HEALTHCONN CORP. is a Taiwan-based Company mainly engaged in the provision of disease prevention and treatment services. The Company is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The Company is also engaged in the medical equipment sale business. The Company operates in the Taiwan market as well as in the mainland China market.
Employees
205
Date Price Change Volume
26-07-09 NT$21.00 0.00% 15,444
26-07-08 NT$21.00 +5.00% 56,145
26-07-07 NT$20.00 -3.85% 14,610
26-07-06 NT$20.80 +4.52% 28,229
26-07-03 NT$19.90 +1.53% 41,630
  1. Stock Market
  2. Stocks
  3. 6665 Stock